Cargando…

A short update on the structure of drug binding sites on neurotransmitter transporters

BACKGROUND: The dopamine (DAT), noradrenalin (NET) and serotonin (SERT) transporters are molecular targets for different classes of psychotropic drugs. Cocaine and the SSRI (S)-citalopram block neurotransmitter reuptake competitively, but while cocaine is a non-selective reuptake inhibitor, (S)-cita...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabrielsen, Mari, Sylte, Ingebrigt, Dahl, Svein G, Ravna, Aina W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259071/
https://www.ncbi.nlm.nih.gov/pubmed/22192271
http://dx.doi.org/10.1186/1756-0500-4-559
_version_ 1782221337350111232
author Gabrielsen, Mari
Sylte, Ingebrigt
Dahl, Svein G
Ravna, Aina W
author_facet Gabrielsen, Mari
Sylte, Ingebrigt
Dahl, Svein G
Ravna, Aina W
author_sort Gabrielsen, Mari
collection PubMed
description BACKGROUND: The dopamine (DAT), noradrenalin (NET) and serotonin (SERT) transporters are molecular targets for different classes of psychotropic drugs. Cocaine and the SSRI (S)-citalopram block neurotransmitter reuptake competitively, but while cocaine is a non-selective reuptake inhibitor, (S)-citalopram is a selective SERT inhibitor. FINDINGS: Here we present comparisons of the binding sites and the electrostatic potential surfaces (EPS) of DAT, NET and SERT homology models based on two different LeuT(Aa )templates; with a substrate (leucine) in an occluded conformation (PDB id 2a65), and with an inhibitor (tryptophan) in an open-to-out conformation (PDB id 3f3a). In the occluded homology models, two conserved aromatic amino acids (tyrosine and phenylalanine) formed a gate between the putative binding pockets, and this contact was interrupted in the open to out conformation. The EPS of DAT and NET were generally negative in the vestibular area, whereas the EPS of the vestibular area of SERT was more neutral. CONCLUSIONS: The findings presented here contribute as an update on the structure of the binding sites of DAT, NET and SERT. The updated models, which have larger ligand binding site areas than models based on other templates, may serve as improved tools for virtual ligand screening.
format Online
Article
Text
id pubmed-3259071
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32590712012-01-17 A short update on the structure of drug binding sites on neurotransmitter transporters Gabrielsen, Mari Sylte, Ingebrigt Dahl, Svein G Ravna, Aina W BMC Res Notes Short Report BACKGROUND: The dopamine (DAT), noradrenalin (NET) and serotonin (SERT) transporters are molecular targets for different classes of psychotropic drugs. Cocaine and the SSRI (S)-citalopram block neurotransmitter reuptake competitively, but while cocaine is a non-selective reuptake inhibitor, (S)-citalopram is a selective SERT inhibitor. FINDINGS: Here we present comparisons of the binding sites and the electrostatic potential surfaces (EPS) of DAT, NET and SERT homology models based on two different LeuT(Aa )templates; with a substrate (leucine) in an occluded conformation (PDB id 2a65), and with an inhibitor (tryptophan) in an open-to-out conformation (PDB id 3f3a). In the occluded homology models, two conserved aromatic amino acids (tyrosine and phenylalanine) formed a gate between the putative binding pockets, and this contact was interrupted in the open to out conformation. The EPS of DAT and NET were generally negative in the vestibular area, whereas the EPS of the vestibular area of SERT was more neutral. CONCLUSIONS: The findings presented here contribute as an update on the structure of the binding sites of DAT, NET and SERT. The updated models, which have larger ligand binding site areas than models based on other templates, may serve as improved tools for virtual ligand screening. BioMed Central 2011-12-22 /pmc/articles/PMC3259071/ /pubmed/22192271 http://dx.doi.org/10.1186/1756-0500-4-559 Text en Copyright ©2011 Ravna et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Gabrielsen, Mari
Sylte, Ingebrigt
Dahl, Svein G
Ravna, Aina W
A short update on the structure of drug binding sites on neurotransmitter transporters
title A short update on the structure of drug binding sites on neurotransmitter transporters
title_full A short update on the structure of drug binding sites on neurotransmitter transporters
title_fullStr A short update on the structure of drug binding sites on neurotransmitter transporters
title_full_unstemmed A short update on the structure of drug binding sites on neurotransmitter transporters
title_short A short update on the structure of drug binding sites on neurotransmitter transporters
title_sort short update on the structure of drug binding sites on neurotransmitter transporters
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259071/
https://www.ncbi.nlm.nih.gov/pubmed/22192271
http://dx.doi.org/10.1186/1756-0500-4-559
work_keys_str_mv AT gabrielsenmari ashortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters
AT sylteingebrigt ashortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters
AT dahlsveing ashortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters
AT ravnaainaw ashortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters
AT gabrielsenmari shortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters
AT sylteingebrigt shortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters
AT dahlsveing shortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters
AT ravnaainaw shortupdateonthestructureofdrugbindingsitesonneurotransmittertransporters